Greg Madison, President and CEO at KERYX BIOPHARMACEUTICALS INC (KERX), sold 1,067 shares at $4.69 ($5K) on 2018-01-05, disclosed to the SEC on 2018-01-08.
Seasonal sale ($5k) by President and CEO — this insider has traded KERX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| KERX | SELL | 2017-10-06 | $6K | — | Filing → |
| KERX | SELL | 2017-08-01 | $29K | — | Filing → |
| KERX | SELL | 2017-07-06 | $7K | — | Filing → |